Cowen Starts Liquidia Technologies (LQDA) at Outperform

Go back to Cowen Starts Liquidia Technologies (LQDA) at Outperform

Needham & Company Starts Liquidia Technologies (LQDA) at Buy

August 20, 2018 6:57 AM EDT

Needham & Company analyst Serge Belanger initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Buy rating and a price target of $30.00.

Belanger commented, "We initiate coverage of Liquidia Technologies (LQDA), a late-stage biopharma developing LIQ861, a differentiated inhaled PAH treatment based on its... More

Jefferies Starts Liquidia Technologies (LQDA) at Buy

August 20, 2018 5:09 AM EDT

Jefferies analyst Matthew Andrews initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Buy rating and a price target of $22.00.

The analyst comments "LQDAs PRINT platform enables it to precisely control a drug particles shape/size with goals of improved... More